Abstract
Staging is one of the most important factors that determine the prognosis of the patients with esophageal adenocarcinoma. The current staging protocol includes parameters—extent of tumor (T), lymph node status (N), presence of distant metastasis (M), and grade of the adenocarcinoma (G). In addition, different criteria are used in patients with and without neoadjuvant therapy. The silent aspects of the use of new staging protocol are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Denoix PF (1946) Enquete permanent dans les centres anticancereaux. Bull Inst Nat Hyg 1:70–75
UICC (1968) TNM pocket book, “the Livre de Poche”, 1st edn
American Joint Committee for Cancer Staging and end results reporting (1977) Manual for staging of cancer. American Joint Committee for Cancer Staging, Chicago, IL
UICC (1987) TNM classification, 4th edn
Beahrs OH, Henson DE, Hutter RVP, Myers MH (eds) (1988) Manual for staging of cancer, 3rd edn. Lippincott, Philadelphia, PA
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) Esophagus and esophagogastric junction. In: AJCC cancer staging manual, 7th edn, Part 3. Springer, New York, pp 103–155, Chapter 10
Rice TW, Kelsen D, Blackstone E, Ishwaran H, Patil DT, Bass AJ, Erasmus JJ, Gerdes H, Hofstetter WL (2016) Esophagus and esophagogastric junction. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) AJCC cancer staging manual, 8th edn. Springer, New York, pp 185–202. Chapter 16
Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH (2009) Worldwide esophageal cancer collaboration. Dis Esophagus 22:1–8
Lam AK (2015) Cellular and molecular biology of esophageal cancer. In: Saba NF, El-Rayes BF (eds) Esophageal cancer: prevention, diagnosis and therapy. Springer, New York, pp 25–40. Chapter 2, ISBN: 978-3-319-20068-2
Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251:46–50
Chen YJ, Schultheiss TE, Wong JY, Kernstine KH (2009) Impact of the number of resected and involved lymph nodes on esophageal cancer survival. J Surg Oncol 100:127–132
Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556
Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH (2017) Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg 265:122–129
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lam, A.K. (2018). Application of Pathological Staging in Esophageal Adenocarcinoma. In: Lam, A. (eds) Esophageal Adenocarcinoma. Methods in Molecular Biology, vol 1756. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7734-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7734-5_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7733-8
Online ISBN: 978-1-4939-7734-5
eBook Packages: Springer Protocols